TIMOTHY RABE: Open Payments
NPI 1023514874 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 51 payments from 12 companies in 2025. Trend: 2023 $305 · 2024 $1,160 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $168 |
| Novo Nordisk Inc | 11 | $163 |
| Amgen Inc. | 11 | $143 |
| GlaxoSmithKline, LLC. | 5 | $91 |
| ABBVIE INC. | 3 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $47 |
| Exact Sciences Corporation | 2 | $46 |
| Corcept Therapeutics | 2 | $39 |
| Lilly USA, LLC | 2 | $31 |
| Medtronic, Inc. | 1 | $23 |
Products named: OTEZLA, Ozempic, FARXIGA, AIRSUPRA, TRELEGY ELLIPTA, JARDIANCE, The Cologuard Plus Collection Kit, Wegovy.
Industry payments across PA — which companies pay providers there.
